Many clinical predictors for poor outcome in patients with Coronavirus disease 2019 (COVID-19) have been discovered, including high levels of inflammatory biomarkers such as interleukin-6 (IL-6), c-reactive protein (CRP), ferritin, and procalcitonin (PCT) [1–14]. The gene discussed is CALCA; the disease is COVID-19.